ETX.L - e-Therapeutics plc

LSE - LSE Delayed Price. Currency in GBp
Currency in GBp

Valuation Measures

Market Cap (intraday) 522.16M
Enterprise Value 310.95M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)206.25
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.66

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Jan 31, 2018
Most Recent Quarter (mrq)Jan 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-27.99%
Return on Equity (ttm)-40.12%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -6.59M
Net Income Avi to Common (ttm)-5.36M
Diluted EPS (ttm)-2.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.6M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.28
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-4.41M
Levered Free Cash Flow (ttm)-3.2M

Trading Information

Stock Price History

Beta -0.23
52-Week Change 3-22.35%
S&P500 52-Week Change 315.07%
52 Week High 310.75
52 Week Low 35.80
50-Day Moving Average 37.26
200-Day Moving Average 37.82

Share Statistics

Avg Vol (3 month) 329.46k
Avg Vol (10 day) 392.79k
Shares Outstanding 5268.6M
Float 200.07M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A